Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
The Danish biotech company confirmed the global study will begin in the second half of 2026
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
Researchers say simple blood-test and echocardiography pathway could reshape diabetes-related cardiovascular care
The new assay consolidates screening for four major viral threats into a single workflow
Subscribe To Our Newsletter & Stay Updated
